## Clinical Assessment & Risk Stratification This patient presents with **severe MDD with high suicide risk**: **Core MDD Criteria Met:** - Depressed mood × 2 weeks - Anhedonia (loss of appetite, inability to engage) - Neurovegetative symptoms: psychomotor retardation, poor appetite - Cognitive symptoms: guilt, worthlessness - Functional impairment: unable to get out of bed **Suicide Risk Factors (HIGH RISK):** - Passive and active suicidal ideation - **Specific, detailed plan** (rope in garage) — highest risk indicator - Male gender - Age >50 years - Social stressor (business failure) - Psychomotor retardation (associated with higher lethality) **Key Point:** Presence of a detailed suicide plan with identified means elevates this to a psychiatric emergency requiring immediate inpatient admission and intensive monitoring. ## Why Inpatient Admission with Observation + Pharmacotherapy ± ECT is Correct **High-Yield:** High suicide risk with a specific plan mandates **immediate psychiatric hospitalization with 1:1 observation** [cite:Harrison 21e Ch 470]. **Management Components:** 1. **Admission to psychiatric ward**: Removes access to means; provides 24/7 monitoring 2. **1:1 observation (suicide watch)**: Standard of care for imminent suicide risk 3. **SSRI initiation** (e.g., sertraline, fluoxetine): First-line pharmacotherapy; takes 2–4 weeks for full effect 4. **ECT consideration**: If no response to SSRI within 1 week or if patient deteriorates, ECT is highly effective for severe, treatment-resistant MDD with suicidality **Clinical Pearl:** ECT has the fastest onset of action (24–72 hours) and highest remission rate (60–80%) in severe MDD with suicidal ideation, especially when combined with pharmacotherapy. **Mnemonic:** **SAFE-ECT** = Suicidal ideation + Acute risk + Functional deterioration + Expect ECT (if SSRI fails in 1 week) ## Why Other Options Are Dangerous ### Option 0: Outpatient SSRI + Follow-up in 1 Week - **Dangerous**: Patient has a detailed suicide plan; outpatient management leaves him unsupervised with access to means - SSRIs take 2–4 weeks to work; risk of suicide is highest in first 2 weeks - Violates duty of care for high-risk patient ### Option 2: Tricyclic Antidepressant (Amitriptyline) + Discharge - **Contraindicated**: Discharge of a patient with detailed suicide plan is negligent - Tricyclics (amitriptyline) are more cardiotoxic and lethal in overdose than SSRIs; inappropriate for suicidal patient - No monitoring or safety planning ### Option 3: Community Mental Health + Psychotherapy Only - **Inadequate**: Psychotherapy alone cannot manage acute suicidality with a specific plan - No pharmacotherapy for severe depression - Insufficient supervision and safety monitoring - Community-based care is appropriate for stable, lower-risk patients, not acute suicidal crisis ## Management Algorithm for Suicidal MDD ```mermaid flowchart TD A[MDD with suicidal ideation]:::outcome --> B{Suicide risk assessment}:::decision B -->|Low risk, no plan| C[Outpatient SSRI + psychotherapy]:::action B -->|Moderate risk, vague plan| D[Intensive outpatient or day hospital]:::action B -->|HIGH RISK: specific plan + means| E[Admit to psychiatric ward]:::urgent E --> F[1:1 observation, remove access to means]:::action F --> G[Start SSRI + psychosocial support]:::action G --> H[Reassess at 1 week]:::decision H -->|Good response| I[Continue inpatient care, taper observation]:::action H -->|No response or worsening| J[Consider ECT]:::action ``` **Warning:** The presence of a **detailed, specific plan** with identified means (rope) is the single strongest predictor of imminent suicide attempt. Outpatient management is contraindicated.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.